Welireg's sNDA for advanced PPGL treatment is under FDA priority review, potentially becoming the first U.S. therapy for this condition. The LITESPARK-015 trial supports the sNDA with ORR and DOR data ...

Merck MRK announced that the FDA has accepted its supplemental new drug application (sNDA) seeking approval of its oral HIF-2α inhibitor, Welireg (belzutifan), for a new indication. The sNDA is ...

London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience. To access our Live RNS you must confirm you are a private ...

Holdingannounced that the U.S. Bankruptcy Court for the Southern District of Texas has extended the expiration of the ...

Trump's tariffs on Canada, Mexico, and China to take effect Saturday, sparking concerns of trade conflicts and price hikes.

Starting tomorrow, those tariffs will be in place,” White House press secretary Karoline Leavitt told reporters. “These are ...

Merck (MRK) announced that the board of directors has declared a quarterly dividend of 81c per share of the company’s common stock for the ...

Merck, known as MSD outside of the United States and Canada, announced the US Food and Drug Administration (FDA) has accepted for priority review a supplemental new drug application (sNDA) seeking ...

Mexican President Claudia Sheinbaum says US tariffs are on hold for a month after talks with President Donald Trump.